Form 4: Medtronic Executive Gregory L. Smith Reports Stock Transaction

EVP Gregory L. Smith reports disposition of Medtronic shares to cover tax obligations upon vesting of restricted stock units.

Summary

• On July 31, 2024, Gregory L. Smith, EVP Global Ops & Supply Chain at Medtronic plc, reported a transaction involving ordinary shares.
• The transaction involved the disposition of 1,406 shares at a price of $80.32.
• This disposition was to cover tax obligations related to the vesting of restricted stock units.
• Following the transaction, Smith beneficially owns 61,267 ordinary shares.

Sentiment

Score: 7

Explanation: The document is a routine regulatory filing detailing a common executive stock transaction. It doesn't indicate any significant positive or negative sentiment, but transparency is generally viewed favorably.

Industry Context

Form 4 filings are standard disclosures required by the SEC when corporate insiders, like Gregory L. Smith, transact in their company's stock. These filings provide transparency into the trading activities of individuals with access to non-public information.

Comparison to Industry Standards

• Executive stock transactions are common across publicly traded companies like Medtronic.
• Companies such as Johnson & Johnson, Abbott Laboratories, and Boston Scientific also see similar filings from their executives.
• The number of shares and the reasons for the transaction (e.g., tax obligations) are typical for executive compensation structures.

Stakeholder Impact

• The transaction has a minimal direct impact on shareholders, as it is a routine executive stock transaction.
• It provides transparency into executive compensation and stock ownership.

Key Dates